FTC and FDA send warning letters to CBD producers

With CBD getting so much attention and so many new companies and celebrities jumping on to the CBD train, it did not come as a complete surprise today when the Federal Trade Commission and Food and Drug Administration issued warning letters Nutra Pure LLC, PotNetwork Holdings, Inc. and Advanced Spine and Pain, LLC (d/b/a Relievus).

The FTC believes that the advertised products may violate the FTC Act by making false or unsubstantiated health claims.

The three companies advertise a range of supplements they say contain cannabidiol, commonly known as CBD, such as “Hemp Oil,” “CBD Softgels,” “Liquid Gold Gummies,” and “CBD Oil.”

According to their advertisements, the products can effectively treat diseases, including cancer, Alzheimer’s disease, fibromyalgia, and “neuropsychiatric disorders.”

In addition, ads for products sold by Nutra Pure, LLC claim that, “Science also shows that CBD has anti-emetic, anti-convulsive, anti-inflammatory and analgesic properties,” and that, “CBD is a viable option for minimizing these effects within the brain.”

Click this link to access the original notification from the FTC.


Please follow and like us:

Categories: CBD, FDA, FTC

Tagged as: , ,

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.